NUVB — Nuvation Bio Inc. Class A Common Stock
7 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about NUVB (2026-11-05)
- NUVB reported Q3 2026 financial results and announced FDA approval for an IBTROZI label update.
- IBTROZI showed 18% sequential growth, accompanied by a $30M milestone announcement.
| Bluesky | 2 | community |
| RSS Bundle | 2 | news |
| GDELT | 1 | news |
| Marketaux | 1 | news |
| SEC EDGAR 8-K | 1 | filings |